We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
A traditional Chinese herbal medicine compound preparation versus interventional therapy after resection of small hepatocellular carcinoma: 22-year follow up
$8.00
VAT Exempt
In stock
SKU
JTCM-545
The five-year recurrence rate of hepatocellular carcinoma (HC) after surgical resection is over 60 per cent. This retrospective study assessed the effects of compound Ruanjianhugan (RJH) tablets in 393 ...
| Author | Sun Zhen et al |
|---|---|
| JCM Issue | JCM101-P80 |
Write Your Own Review
* Orders shipped outside of Europe are eligible for VAT relief and will not be charged VAT.